Cronos Group Dividend

Dividend criteria checks 0/6

Cronos Group does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.3%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.18
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

Cronos Stock: Attractive Now With Cannabis Legalization In Germany

Mar 04

Cronos Group: Flush With Cash And Trading Below Book Value

Feb 11

Cronos Group GAAP EPS of -$0.05 beats by $0.01, revenue of $23.1M misses by $5.25M

Aug 09

Cronos Group: Too Much Cash, Too Soon - Making The Bear Case

Aug 01

Cronos Group: High Hurdles

May 11

Cronos Earnings: Cannabis Stock With 65% Net Cash And 51% Revenue Growth

Mar 01

Cronos Group Late-Filed Q3-2021 Earnings Show Revenues From Synthetic Cannabinoids

Feb 22

Cronos Group: Still No Reason To Own

Jan 22

Cronos Group Strategic Investor Altria May Be About To Buy The Balance

Nov 08

After Cronos Finally Invests In U.S. Cannabis, Is The Stock A Buy?

Aug 30

Is Cronos Stock Worth Buying? Probably, But Patience Remains A Requirement

Jul 12

Cronos Group stock rises 2.6% with acquisition of 10.5% stake in PharmaCann

Jun 14

Cronos Group: Still Hasn't Launched

May 09

Cronos Group Q1 Earnings Preview

May 06

Cronos: The Most Confusing Cannabis Stock

Apr 28

Cronos: Sitting On Your Hands Is Not A Winning Strategy

Jan 03

Cronos Group (CRON) Investor Presentation - Slideshow

Nov 24

Cronos Is A Buy With Increasing Revenues

Nov 18

Cronos shares rise 5% on solid Q3 beat; top-line +96% boosted by advancement in Canadian/Israeli market

Nov 05

Cronos: Failure To Launch

Nov 03

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CRON's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CRON's dividend payments have been increasing.


Dividend Yield vs Market

Cronos Group Dividend Yield vs Market
How does CRON dividend yield compare to the market?
SegmentDividend Yield
Company (CRON)n/a
Market Bottom 25% (US)1.6%
Market Top 25% (US)4.8%
Industry Average (Pharmaceuticals)2.3%
Analyst forecast in 3 Years (CRON)0%

Notable Dividend: Unable to evaluate CRON's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CRON's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate CRON's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CRON has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.